已收盘 05-31 16:00:00 美东时间
0.000
0.00%
Kuros Biosciences AG ("Kuros" or the "Company"), a leader in next generation bone graft technologies, notes the completion of the acquisition of Checkmate Pharmaceuticals (NASDAQ: CMPI) by Regeneron Pharmaceuticals (NASDAQ: REGN).
2022-06-02 17:29
03:43 AM EDT, 06/02/2022 (MT Newswires) -- Regeneron Pharmaceuticals (REGN) has...
2022-06-02 15:44
CAMBRIDGE, Mass., May 26, 2022 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, I...
2022-05-27 05:05
Checkmate Pharmaceuticals (NASDAQ:CMPI) reported quarterly losses of $(0.73) per share. This is a 12.31 percent decrease over losses of $(0.65) per share from the same period last year.
2022-05-13 05:06
07:26 AM EDT, 04/20/2022 (MT Newswires) -- (MT Newswires covers equity, commodi...
2022-04-20 19:31
NEW YORK , April 19, 2022 /PRNewswire/ -- Weiss Law is investigating possible b...
2022-04-20 04:21
查看最新行情 北京时间19日晚,美股周二开盘涨跌不一。美债收益率继续攀升,10年期美债收益率创2018年底以来新高。本周财报密集出炉,投资者在...
2022-04-19 21:30
周二,再生元制药公司(REGN.US)已同意以每股10.50美元的价格全现金收购临床阶段生物技术公司Checkmate Pharmaceuticals(CMP...
2022-04-19 20:05
07:25 AM EDT, 04/19/2022 (MT Newswires) -- Regeneron Pharmaceuticals (REGN) and...
2022-04-19 19:30
11:24 AM EDT, 03/30/2022 (MT Newswires) -- (MT Newswires covers equity, commodi...
2022-03-30 23:27